A detailed history of Advisory Resource Group transactions in Novo Nordisk A S stock. As of the latest transaction made, Advisory Resource Group holds 7,468 shares of NVO stock, worth $759,794. This represents 0.27% of its overall portfolio holdings.

Number of Shares
7,468
Previous 7,317 2.06%
Holding current value
$759,794
Previous $939,000 13.42%
% of portfolio
0.27%
Previous 0.24%

Shares

12 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Jul 24, 2024

BUY
$122.71 - $146.91 $18,529 - $22,183
151 Added 2.06%
7,468 $1.07 Million
Q1 2024

May 17, 2024

BUY
$102.11 - $135.92 $84,036 - $111,862
823 Added 12.67%
7,317 $939,000
Q4 2023

Jan 11, 2024

SELL
$87.78 - $105.45 $42,924 - $51,565
-489 Reduced 7.0%
6,494 $671,000
Q3 2023

Dec 05, 2023

BUY
$90.94 - $199.54 $318,744 - $699,387
3,505 Added 100.78%
6,983 $635,000
Q2 2023

Jul 11, 2023

SELL
$155.98 - $172.65 $50,693 - $56,111
-325 Reduced 8.55%
3,478 $562,000
Q1 2023

May 15, 2023

SELL
$132.34 - $159.14 $44,598 - $53,630
-337 Reduced 8.14%
3,803 $605,000
Q4 2022

Jan 27, 2023

BUY
$102.55 - $135.33 $424,557 - $560,266
4,140 New
4,140 $0
Q2 2022

Jul 21, 2022

SELL
$103.24 - $121.81 $44,806 - $52,865
-434 Reduced 16.76%
2,156 $240,000
Q1 2022

Apr 06, 2022

BUY
$93.1 - $112.54 $18,526 - $22,395
199 Added 8.32%
2,590 $288,000
Q4 2021

Feb 08, 2022

BUY
$95.88 - $117.08 $27,421 - $33,484
286 Added 13.59%
2,391 $239,000
Q3 2021

Oct 26, 2021

SELL
$84.42 - $106.62 $25,157 - $31,772
-298 Reduced 12.4%
2,105 $202,000
Q2 2021

Aug 19, 2021

BUY
$67.66 - $84.76 $162,586 - $203,678
2,403 New
2,403 $201,000

Others Institutions Holding NVO

About NOVO NORDISK A S


  • Ticker NVO
  • Exchange OTC
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 2,257,289,984
  • Market Cap $230B
  • Description
  • Novo Nordisk A/S, a healthcare company, engages in the research, development, manufacture, and marketing of pharmaceutical products worldwide. It operates in two segments, Diabetes and Obesity care, and Biopharm. The Diabetes and Obesity care segment provides products in the areas of insulins, GLP-1 and related delivery systems, oral antidiabeti...
More about NVO
Track This Portfolio

Track Advisory Resource Group Portfolio

Follow Advisory Resource Group and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Advisory Resource Group, based on Form 13F filings with the SEC.

News

Stay updated on Advisory Resource Group with notifications on news.